<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04818762</url>
  </required_header>
  <id_info>
    <org_study_id>pFTOE</org_study_id>
    <nct_id>NCT04818762</nct_id>
  </id_info>
  <brief_title>Peripheral Fractional Tissue Oxygen Extraction and Infection in Term and Preterm Neonates</brief_title>
  <acronym>pFTOE</acronym>
  <official_title>Peripheral Fractional Tissue Oxygen Extraction and Infection in Term and Preterm Neonates - a Prospective Pilot Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational pilot study investigating if peripheral fractional tissue&#xD;
      oxygen extraction (pFTOE) measured by five short near-infrared spectroscopy (NIRS)&#xD;
      (re-)applications within the first 6 hours after birth in neonates with respiratory distress&#xD;
      differs in neonates with early onset infection and neonate without infection&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background Near-infrared spectroscopy (NIRS) enables non-invasive, continuous monitoring of&#xD;
      oxygenation and perfusion in different tissues. In several studies NIRS has been described to&#xD;
      have the potential to detect centralisation due to perfusion heterogeneity, arterio-venous&#xD;
      shunting and impaired autoregulation. Thus, peripheral muscle NIRS measurement has the&#xD;
      potential to provide information at early stages of inflammation also due to infection, due&#xD;
      to microvascular dysfunction, when other routine vital parameters are still within normal&#xD;
      ranges.&#xD;
&#xD;
      Objectives&#xD;
&#xD;
      Primary aim To assess, if pFTOE measured by five short NIRS (re-)applications within the&#xD;
      first 6 hours after birth differs in neonates with early onset infection and neonates without&#xD;
      infection.&#xD;
&#xD;
      Secondary aims To assess, if cerebral fractional tissue oxygen extraction (cFTOE) and&#xD;
      cFTOE/pFTOE measured by five short NIRS (re-)applications within the first 6 hours after&#xD;
      birth differs in neonates with early onset infection and neonates without infection. To&#xD;
      assess, if there is a difference in pFTOE, cFTOE and cFTOE/pFTOE between term and preterm&#xD;
      neonates.&#xD;
&#xD;
      Methods&#xD;
&#xD;
      Study population: Term and preterm neonates ≥30+0 weeks of gestation with respiratory&#xD;
      distress and risk factors for infection admitted to the neonatal intensive care unit (NICU)&#xD;
      on the first day after vaginal delivery or caesarean section on the first day after birth&#xD;
      will be eligible for this study. Inclusion criteria are signs of respiratory distress at&#xD;
      time-point of inclusion, age &lt;6h and decision to conduct full life support. There will be&#xD;
      four groups consisted with term(1) and preterm(2) neonates with early onset infection and&#xD;
      term(3) and preterm(4) neonates without.&#xD;
&#xD;
      Procedure: Patients and maternal medical history, routinely sampled laboratory results and&#xD;
      blood culture will be documented in each neonate.&#xD;
&#xD;
      Measurement: The NIRS-measurement will take place once within 6 hours after birth. For NIRS&#xD;
      measurements the NIRO 200NX will be used and the NIRS sensors will be applied by hand on the&#xD;
      right forearm (pTOI) and on the left forehead (cTOI) until stable signals are obtained for&#xD;
      approximately 30 seconds, respectively. Then the sensors will be removed for 10sec rest&#xD;
      period. After that the sensors will be reapplied in approximately the same positions. This&#xD;
      procedure will be repeated five times.&#xD;
&#xD;
      Level of originality As many term and preterm neonates are admitted to the NICU after birth&#xD;
      due to respiratory distress, there is growing interest in methods enabling to recognize&#xD;
      subtle early signs like micro-vascular dysfunction due to infection. In the present study the&#xD;
      investigators want to evaluate in neonates with respiratory distress if peripheral muscle and&#xD;
      cerebral FTOE measured by short reapplications with NIRS in the first hours after birth&#xD;
      enables to recognize early microvascular dysfunction and compromised oxygenation due to&#xD;
      infections.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pFTOE</measure>
    <time_frame>5 minutes (duration of 5 re-applications)</time_frame>
    <description>pFTOE within 6 hours after birth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cFTOE</measure>
    <time_frame>5 minutes (duration of 5 re-applications)</time_frame>
    <description>cFTOE and cFTOE/pFTOE within 6 hours after birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gestational age</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>term and preterm neonates</description>
  </secondary_outcome>
  <other_outcome>
    <measure>TOI</measure>
    <time_frame>5 minutes (duration of 5 re-applications)</time_frame>
    <description>cTOI, pTOI</description>
  </other_outcome>
  <other_outcome>
    <measure>routine monitoring data - arterial oxygen saturation (SpO2)</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>SpO2 in percentage (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>routine monitoring data - heart rate (HR)</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>HR im beats per minute (bpm)</description>
  </other_outcome>
  <other_outcome>
    <measure>routine monitoring data - blood pressure (RR)</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>RR in mmHg</description>
  </other_outcome>
  <other_outcome>
    <measure>routine monitoring data (temperature)</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>temperature in °C</description>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameter</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>C reactive protein (mg/l) - routinely sampled</description>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameter</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>leukocytes (per µl) - routinely sampled</description>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameter</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>IT-ratio - routinely sampled</description>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameter</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>blood cultures - routinely sampled</description>
  </other_outcome>
  <other_outcome>
    <measure>Demographic data of the neonate</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>gestational age (weeks)</description>
  </other_outcome>
  <other_outcome>
    <measure>Demographic data of the neonate</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>birth weight (grams)</description>
  </other_outcome>
  <other_outcome>
    <measure>Demographic data of the neonate</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>risk factors</description>
  </other_outcome>
  <other_outcome>
    <measure>Data of the neonate</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>diagnosis (descriptive)</description>
  </other_outcome>
  <other_outcome>
    <measure>Data of the neonate</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>therapy (descriptive)</description>
  </other_outcome>
  <other_outcome>
    <measure>Medication</measure>
    <time_frame>up to 10 weeks (until term age - discharge)</time_frame>
    <description>medication in appropriate dosage</description>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Neonatal Infection</condition>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Preterm neonates with infection</arm_group_label>
    <description>Preterm neonates (30+0 - 36+6 weeks of gestation) with clinical and laboratory signs of early onset infection (within 72 hours after birth).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm neonates without infection</arm_group_label>
    <description>Preterm neonates (30+0 - 36+6 weeks of gestation) without clinical and laboratory signs of early onset infection (within 72 hours after birth).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term neonates with infection</arm_group_label>
    <description>Preterm neonates (30+0 - 36+6 weeks of gestation) with clinical and laboratory signs of early onset infection (within 72 hours after birth).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term neonates without infection</arm_group_label>
    <description>Preterm neonates (30+0 - 36+6 weeks of gestation) without clinical and laboratory signs of early onset infection (within 72 hours after birth).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Term and preterm neonates ≥30+0 weeks of gestation with respiratory distress and risk&#xD;
        factors for infection admitted to the Division of Neonatology, Department of Pediatrics and&#xD;
        Adolescent Medicine, Medical University of Graz after vaginal delivery or caesarean section&#xD;
        on the first day after birth will be eligible for the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signs of respiratory distress at time-point of inclusion (tachypnoea &gt;60/minutes,&#xD;
             grunting, intercostal/subcostal/jugular retractions, nasal flaring, supplemental&#xD;
             oxygen or respiratory upport)&#xD;
&#xD;
          -  Decision to conduct full life support&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Age &lt; 6 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No decision to conduct full life support&#xD;
&#xD;
          -  no written informed consent&#xD;
&#xD;
          -  gestational age &lt;30+0 weeks of gestation&#xD;
&#xD;
          -  age &gt; 6 hours&#xD;
&#xD;
          -  severe congenital malformations, severe asphyxia (umbilical cord artery pH &lt;7.00)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Pichler, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz, Department of Pediatric and Adolescent Medicine, Division of Neonatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerhard Pichler, Prof., MD</last_name>
    <phone>0043 316 385 80520</phone>
    <email>gerhard.pichler@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christina Wolfsberger, MD</last_name>
    <phone>0043 316 385 81135</phone>
    <email>christina.wolfsberger@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Pediatrics, Division of Neonatology, Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Pichler, MD</last_name>
      <phone>0043 316 385 80520</phone>
      <email>gerhard.pichler@medunigraz.at</email>
    </contact>
    <investigator>
      <last_name>Gerhard Pichler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 15, 2021</study_first_submitted>
  <study_first_submitted_qc>March 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2021</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

